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Background and objectives
Patients with Dilated Cardiomyopathy (DCM) and
Hypertrophic Cardiomyopathy (HCM) frequently
demonstrate non-ischemic pattern myocardial fibrosis
(MF) on delayed enhancement magnetic resonance
imaging (DE-MRI). The clinical significance of this
finding with respect to impact on Quality of Life
(QOL) is poorly understood. In this study we identify
the prevalence of MF in patients with HCM and DCM
and assess its relationship with standardized measures
of QOL.
Methods
One-hundred and seven consecutive patients with
either DCM (n=50) or HCM (n=57) referred for MRI
evaluation were identified. DCM was defined as a
LVEF <40% and no significant coronary disease by
angiography. HCM was defined by standard echocar-
diographic criteria. All patients completed both the
Minnesota Living With Heart Failure (MLWHF) and
SF-12 QOL questionnaires at time of MRI. A standard
DE-MRI protocol was performed 10 minutes following
the administration of intravenous gadolinium (Gado-
vist®, Bayer Inc). DE images were both visually scored
using a validated 68 sub-segment segment model and
quantitatively analyzed for signal enhancement (thresh-
old >3SD above reference myocardium) using validated
commercial software.
Results
Mean age for DCM and HCM groups was 59 (±13.4)
and 53 (±12.1) years respectively with a mean ejection
fraction of 34.7 ±16.9% and 74.2 ±10.8 % respectively.
T h er e s p e c t i v em e a nN Y H Ac l a s so ft h e2g r o u p sw a s
2.0 ±0.9 and 1.4 ±1.1. The prevalence of any MF on
visual scoring was 64% in the DCM group and 82% in
those with HCM. By quantitative evaluation there was
significantly more MF detected in patients with HCM
than in DCM (19.2% vs. 13.1% of LV mass (p=0.008)).
QOL, as assessed by MHLWF, was not significantly
different in patients with any MF versus those without
for either the DCM group (39.9 vs. 26.1, p=0.067) or
HCM group (28.7 vs. 26.1, p=0.45). The SF12 physical
and mental scores were also similar for both the DCM
group (46.4 vs. 50.2 (p=0.25), and 46.2 vs. 44.4
(p=0.83), respectively) andH C Mg r o u p( 4 0 . 4v s .4 5 . 5
(p=0.36), and 46.2 vs. 44.4 (p=0.83), respectively).
There was no correlation found between the quantita-
tive volume of MF and any QOL score in either
patient group.
Conclusion
MF is common in patients with DCM and HCM. How-
ever, its presence and severity is not correlated with
reductions in QOL relative to patients without MF. Pro-
spective studies to evaluate the impact of MF on the
natural history of disease progression and interim
change in QOL are underway.
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